Overview

The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to assess the efficacy of LMWH treatment in women with unexplained infertility and negative immunological markers undergoing ICSI.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ain Shams University
Treatments:
Enoxaparin
Heparin, Low-Molecular-Weight
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- age less than 38 years

- at least 12 months of infertility

- women with unexplained infertility

Exclusion Criteria:

- age more than or equals 38 years

- serum AMH level less than or equals 1 ng/ml

- patients of anticoagulant therapy

- immune-compromised patients

- patients with contraindications to low molecular weight heparin

- positive immunological markers

- patients with other than unexplained infertility

- male factor infertility

- refusal of participation

- patients with unexpected poor or over response during induction of ovulation